In the above-mentioned article, the authors want to update the errors in Results and
Table 3, specifically the errors in the percentages and the subheadings with clearer meaning. The authors regret this error and would like to apologize for any inconvenience caused.
In the result section, “Of 63 cases, 96.8% were reported to have comorbidities: 47.6% hypertension, 36.5% diabetes, 16% neurodegenerative disorders, and 17.5% pulmonary diseases.” should be changed to: “Of 66 cases, 92.4% were reported to have comorbidities: 45.4% hypertension, 34.8% diabetes, 24.2% neurodegenerative disorders, and 16.7% pulmonary diseases”.
The results related to fatal cases in
Table 3 should be changed as follows.
Table 3Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.
Table 3
| Variables |
n |
(%) |
| Age, years, median (range) |
77 |
(35–93) |
|
| Sex |
| Female |
29 |
(43.9) |
| Male |
37 |
(56.1) |
|
| Coexisting condition*
|
| Any |
61 |
(92.4) |
| Cerebrovascular disease |
5 |
(7.6) |
| Heart disease |
10 |
(15.2) |
| Pulmonary disease |
11 |
(16.7) |
| Kidney disease |
5 |
(7.6) |
| Diabetes |
23 |
(34.8) |
| Hypertension |
30 |
(45.4) |
| Cancer |
7 |
(10.6) |
| Neurodegenerative disorder |
16 |
(24.2) |
| Under investigation |
5 |
(7.6) |
|
| Region |
| Daegu |
47 |
(71.2) |
| Gyeongbuk |
16 |
(24.2) |
| Others |
3 |
(4.5) |
|
| Death before admission |
5 |
(7.6) |
| Interval, days, median (range) |
| Symptom → Death |
10 |
(1–24) |
| Symptom → Diagnosis |
4 |
(0–20) |
| Symptom → Hospitalization |
4.5 |
(0–11) |
| Hospitalization → Death |
5 |
(0–16) |
|
| Total |
66 |
|
Citations
Citations to this article as recorded by
- Effect of COVID-19-Related Interventions on the Incidence of Infectious Eye Diseases: Analysis of Nationwide Infectious Disease Incidence Monitoring Data
Woo-Ri Lee, Li-Hyun Kim, Gyeong-Min Lee, Jooyoung Cheon, Young Dae Kwon, Jin-Won Noh, Ki-Bong Yoo
International Journal of Public Health.2022;[Epub] CrossRef - Clinical Outcomes and Severity of Acute Respiratory Distress Syndrome in 1154 COVID-19 Patients: An Experience Multicenter Retrospective Cohort Study
Abbas Al Mutair, Saad Alhumaid, Laila Layqah, Jinan Shamou, Gasmelseed Y. Ahmed, Hiba Chagla, Khulud Alsalman, Fadhah Mohammed Alnasser, Koritala Thoyaja, Waad N. Alhuqbani, Mohammed Alghadeer, Mohammed Al Mohaini, Sana Almahmoud, Jaffar A. Al-Tawfiq, Jav
COVID.2022; 2(8): 1102. CrossRef - The Reopening of Schools and Adoption of Universal Wearing of Face Masks in Anticipation of Sustained Transmission or the Second Wave of COVID-19 with the Influenza Virus
Sasho Stoleski, Cameron Y. S. Lee
Journal of Public Health International.2020; 3(1): 1. CrossRef - Management of Diabetes in Coronavirus Disease 2019: Prognosis and Practical Issues
Hye Soon Kim
The Journal of Korean Diabetes.2020; 21(3): 120. CrossRef
